Thermo Fisher Scientific Inc. (ETR: TN8)

Market Cap	192.43B
Revenue (ttm)	37.95B
Net Income (ttm)	5.50B
Shares Out	n/a
EPS (ttm)	14.29
PE Ratio	35.02
Forward PE	n/a
Dividend	1.44 (0.29%)
Ex-Dividend Date	Dec 13, 2024

Volume	283
Open	496.00
Previous Close	505.80
Day's Range	491.50 - 501.00
52-Week Range	469.65 - 575.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechno...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 122,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2023, Thermo Fisher Scientific's revenue was $42.86 billion, a decrease of -4.58% compared to the previous year's $44.92 billion. Earnings were $6.00 billion, a decrease of -13.74%.

Financial numbers in USD